Management of Bicuspid Aortic Valve
All patients with bicuspid aortic valve require comprehensive transthoracic echocardiography at diagnosis to assess valve function (stenosis or regurgitation severity) and measure aortic dimensions at multiple levels: annulus, sinuses of Valsalva, sinotubular junction, and mid-ascending aorta. 1
Initial Diagnostic Evaluation
Echocardiographic Assessment
- Measure aortic dimensions at four critical levels: aortic annulus, sinuses of Valsalva, sinotubular junction, and mid-ascending aorta 1
- Assess valve morphology to determine cusp fusion pattern (right-left coronary cusp fusion versus right/left-noncoronary cusp fusion), as fusion involving the noncoronary cusp carries higher risk of aortic dilation (68% versus 40%) 1
- Perform Doppler interrogation of the proximal descending aorta to evaluate for associated aortic coarctation 1
- Quantify stenosis severity using standard gradients and valve area, or regurgitation severity using standard parameters 1
Advanced Imaging
- Obtain cardiac MRI or CT angiography when echocardiography cannot adequately visualize the ascending aorta beyond 4.0 cm from the valve plane 1
- MRI is preferred over CT to avoid cumulative radiation exposure in patients requiring lifelong surveillance 1, 2
- These modalities provide superior spatial resolution and 3D reconstruction of the entire aorta, though measurements are typically 1-2 mm larger than echocardiographic values 1
Family Screening
- Screen first-degree relatives with echocardiography, as 20-30% will have bicuspid valve disease or associated aortopathy 1
- Screening is clearly indicated if the patient has aortopathy or family history of valvular heart disease or aortopathy 1
Surveillance Strategy
For Aortic Dimensions <4.0 cm
- Follow with transthoracic echocardiography alone at intervals based on valve dysfunction severity 2
- Repeat aortic imaging every 3-5 years if mild aortic dilation is present 2
For Aortic Dimensions 4.0-4.5 cm
- Perform serial imaging (echocardiography, MRI, or CT) at intervals determined by rate of progression and family history 1
For Aortic Dimensions >4.5 cm
- Perform annual imaging with echocardiography, MRI, or CT angiography 1
- Expected progression rates: 0.5 mm/year at sinuses and sinotubular junction, 0.9 mm/year at proximal ascending aorta (though rates up to 2 mm/year have been reported) 1
Valve Function Monitoring
- Annual echocardiography for patients with moderate aortic stenosis or regurgitation to assess left ventricular function, gradients, valve area (stenosis), or LV dimensions (regurgitation) 2
- Annual clinical evaluation for symptom changes or functional capacity decline 2
Medical Management
Blood Pressure Control
- Control hypertension with any effective antihypertensive agent 1
- Beta-blockers and ARBs have theoretical advantages but lack proven benefit in clinical studies for slowing aortic dilation 1
- No proven medical therapies exist to reduce progression of BAV-associated aortopathy 1
Surgical Indications
Isolated Aortopathy (Without Severe Valve Dysfunction)
Primary Indication:
- Operate when aortic diameter exceeds 5.5 cm at any level (sinuses, sinotubular junction, or ascending aorta) 1
Earlier Intervention (5.0-5.5 cm):
- Operate at diameters 5.1-5.5 cm if family history of aortic dissection OR rapid progression ≥0.5 cm/year 1
- Do not adjust aortic diameter thresholds for body surface area 1
Concomitant Aortic Surgery During Valve Replacement
- Replace ascending aorta when diameter exceeds 4.5 cm in patients undergoing aortic valve replacement for severe stenosis or regurgitation 1
- Replacement of sinuses of Valsalva should be individualized based on coronary ostia displacement, as progressive sinus dilation after isolated ascending aorta replacement is uncommon 1
Valve-Specific Interventions
- Balloon aortic valvuloplasty may serve as temporizing treatment in young adults with isolated aortic stenosis 2
- Aortic valve replacement (with or without aortic surgery) is indicated for severe stenosis or regurgitation based on standard criteria 2
Critical Pitfalls to Avoid
- Do not rely solely on echocardiography if the ascending aorta cannot be visualized adequately—obtain MRI or CT 1
- Do not miss the cusp fusion pattern—patients with noncoronary cusp involvement have higher risk of extensive aortic dilation extending to the transverse arch 1
- Do not forget to evaluate for aortic coarctation with Doppler interrogation of the descending aorta 1
- Do not delay family screening—20-30% of first-degree relatives are affected 1
- The absolute risk of dissection remains low (3.1 per 10,000 patient-years), though 8.4 times higher than age-matched controls 1